首页> 外文期刊>Journal of cardiovascular electrophysiology >Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation
【24h】

Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation

机译:经皮萃取和重新定位:心脏装置植入后心包囊内外脱位的早期室性铅穿孔的有效和安全的治疗策略

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Introduction Cardiac perforation of the right ventricle associated with pacemaker or implantable cardioverter defibrillator (ICD) leads’ implantation is uncommon, albeit potentially life‐threatening, complication. The aim of this study is to further identify the optimal therapeutic strategy, especially when lead dislocation has occurred outside the pericardial sac. Methods and Results The study population included 10 consecutive patients (six female, mean age: 66.5 years old) diagnosed with early ventricular lead perforation following a pacemaker or ICD implantation, with significant protrusion inside the pericardial sac ( n ?=?2) or migration of the lead at the pleural space ( n ?=?3), the diaphragm ( n ?=?1), or the abdominal cavity ( n ?=?4), during the period 2013‐2017. All patients were symptomatic; however, individuals presenting with hemodynamic instability were excluded. The outcome of the percutaneous therapeutic approach was retrospectively assessed. All patients underwent a successful removal of the perforating lead percutaneously at the electrophysiology lab, by direct traction, and repositioning in another location of the right ventricle. The operation was performed by a multidisciplinary team, under continuous hemodynamic and transesophageal echocardiographic monitoring and cardiac surgical backup. The periprocedural period was uneventful. Subjects were followed up for at least 1 year. Interestingly, all patients developed a type of postcardiac injury syndrome, successfully treated with a 3‐month regimen of ibuprofen and colchicine. Conclusion Percutaneous traction and repositioning of the perforating ventricular lead are effective, safe, and less invasive compared with the thoracotomy method in hemodynamically stable patients when dislocation has occurred outside the pericardial sac provided that there is no visceral organs injury.
机译:摘要介绍与起搏器或可植入心脏除颤器相关的右心室的心脏穿孔(ICD)引线植入罕见,尽管威胁危及生命,并发症。本研究的目的是进一步确定最佳的治疗策略,尤其是当铅位错发生在心包囊外时。方法和结果研究人群包括连续10名患者(六名女性,意种年龄:66.5岁)被诊断出现在起搏器或ICD植入后的早期心室铅穿孔,在心包囊内具有显着的突起(n?= 2)或迁移在胸腔空间(n?=α3)处的铅(n?=Δ3),在2013-2017期间,隔膜(n?=Δ1),或腹腔(n?=Δ4)。所有患者均症状;但是,排除了血液动力学不稳定的个体被排除在外。回顾性评估了经皮治疗方法的结果。所有患者通过直接牵引力,通过直接牵引力,在电生理学实验室,在右心室的另一个位置进行重新定位,均经历了穿孔铅的穿孔铅。该操作是由多学科团队进行的,在连续血液动力学和经细胞反响超声心动图监测和心脏手术备份下进行。霸权时期是不行的。受试者跟进至少1年。有趣的是,所有患者都开发了一种成功治疗的白醛和秋水仙碱的3个月方案。结论在血流动力学稳定的患者外部在心包囊外的脱位发生时,皮带牵引和孔隙术铅的重新定位是有效的,安全,较少的侵袭性,因为没有内脏的器官损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号